Canada | The Draft Screening Assessment 2H-azepin-2-one, hexahydro- (caprolactam) was published for a 60-day public comment period ending on October 13, 2021

This substance was identified for action under the Chemicals Management Plan (CMP).

Summary of publications
CAS RN	Common name	DSL name	Draft screening assessment	Proposed conclusion on section 64 criteria	Follow-up activities
105-60-2	Caprolactam	H-Azepin-2-one, hexahydro-	HTML	Does not meet	None planned at this time

CONTINUE READING ON: www.canada.ca

Your substances